{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1420564276158716672.json","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00596306"},{"@type":"NRID","@value":"1000000596306"},{"@type":"NRID","@value":"9000398147872"},{"@type":"NRID","@value":"9000265260288"},{"@type":"NRID","@value":"9000403303474"},{"@type":"NRID","@value":"9000387299634"},{"@type":"NRID","@value":"9000402374893"}],"foaf:Person":[{"foaf:name":[{"@language":"ja","@value":"熊井 琢美"},{"@language":"ja-Kana","@value":"クマイ タクミ"}],"foaf:familyName":[{"@language":"ja","@value":"熊井"},{"@language":"ja-Kana","@value":"クマイ"}],"foaf:givenName":[{"@language":"ja","@value":"琢美"},{"@language":"ja-Kana","@value":"タクミ"}]}],"career":[{"institution":{"notation":[{"@value":"旭川医科大学"}]},"department":{"notation":[{"@value":"医学部"}]},"jobTitle":{"notation":[{"@value":"講師"}]},"since":"2026","until":"2026"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781926534528","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16K20223"},{"@type":"JGN","@value":"JP16K20223"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K20223/"}],"notation":[{"@language":"ja","@value":"頭頸部癌に対する分子標的薬を中心としたアジュバントによる免疫療法の開発"},{"@language":"en","@value":"Combination of molecular-targeted therapy with peptide vaccine"}],"role":"研究代表者(Principal Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040000781993518464","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"18H02948"},{"@type":"JGN","@value":"JP18H02948"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18H02948/"}],"notation":[{"@language":"ja","@value":"鼻性NK/T細胞リンパ腫における免疫抑制機構の解明と新規免疫療法の開発"},{"@language":"en","@value":"Developing novel immunotherapy against nasal NK/T cell lymphoma"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040003825726129152","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"20K11066"},{"@type":"JGN","@value":"JP20K11066"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K11066/"}],"notation":[{"@language":"ja","@value":"高齢頭頸部癌患者の化学放射線療法による有害事象に対する口腔内評価ツールの開発"},{"@language":"en","@value":"Development of an oral assessment tool for chemoradiotherapy-induced adverse events in elderly head and neck cancer patients."}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040282257177471104","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24390385"},{"@type":"JGN","@value":"JP24390385"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24390385/"}],"notation":[{"@language":"ja","@value":"鼻性ＮＫ／Ｔ細胞リンパ腫に対するＥＢウイルス・腫瘍増殖分子標的治療の基盤的研究"},{"@language":"en","@value":"A foundational study for targeted therapy against EB virus and tumor growth factor in nasal NK/T-cell lymphoma"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040282257208105728","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24791735"},{"@type":"JGN","@value":"JP24791735"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24791735/"}],"notation":[{"@language":"ja","@value":"ＥｒｂＢファミリーを標的とした頭頸部癌の免疫治療に向けた基盤研究"},{"@language":"en","@value":"HER family targeted immunotherapy against head and neck squamous cancer"}],"role":"研究代表者(Principal Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040285300702069632","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"20K09724"},{"@type":"JGN","@value":"JP20K09724"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K09724/"}],"notation":[{"@language":"ja","@value":"頭頸部癌に対する免疫チェックポイント阻害薬のバイオマーカー探索"},{"@language":"en","@value":"Biomarkers to select the immune checkpoint inhibitor-responder in head and neck cancer"}],"role":"研究代表者(Principal Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040287907237313664","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21H03082"},{"@type":"JGN","@value":"JP21H03082"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H03082/"}],"notation":[{"@language":"ja","@value":"鼻性NK/T細胞リンパ腫を治癒に導く複合的免疫療法の確立"},{"@language":"en","@value":"Establishment of novel immunotherapy against nasal NK/T cell lymphoma"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040291932593350016","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22K09699"},{"@type":"JGN","@value":"JP22K09699"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K09699/"}],"notation":[{"@language":"ja","@value":"扁桃における糖鎖不全IgAとT細胞サブセットを中心としたIgA腎症の病態解明"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040295802074262912","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K08903"},{"@type":"JGN","@value":"JP23K08903"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K08903/"}],"notation":[{"@language":"ja","@value":"扁桃病巣疾患における基礎的、臨床的エビデンスの構築"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040295802074279040","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K08929"},{"@type":"JGN","@value":"JP23K08929"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K08929/"}],"notation":[{"@language":"ja","@value":"TRK阻害薬を用いた頭頸部癌およびその神経浸潤と免疫逃避に対する新規治療法の開発"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040295802074300288","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K08977"},{"@type":"JGN","@value":"JP23K08977"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K08977/"}],"notation":[{"@language":"ja","@value":"頭頸部癌特異的T細胞を活用した複合型免疫療法の開発"}],"role":"研究代表者(Principal Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040304161925424768","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25K00340"},{"@type":"JGN","@value":"JP25K00340"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25K00340/"}],"notation":[{"@language":"ja","@value":"エピジェネティクスを活用した新規Pentraxin-3特異的免疫療法の開発"}],"role":"研究分担者/共同研究者(Co-Investigator)"},{"@id":"https://cir.nii.ac.jp/crid/1040870850683710720","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26K12404"},{"@type":"JGN","@value":"JP26K12404"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26K12404/"}],"notation":[{"@language":"ja","@value":"リンパ節転移を標的とした革新的頭頸部癌免疫療法の開発"}],"role":"研究代表者(Principal Investigator)"}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1010000781926534534","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI_AS_WRITTEN","@value":"10.1158/2326-6066"}],"notation":[{"@language":"ja","@value":"Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1010566775576488194","@type":"Article","resourceType":"学術雑誌論文(journal article)","notation":[{"@language":"ja","@value":"鼻性NK/T細胞リンパ腫に対する革新的免疫療法の開発"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1010584168958685952","@type":"Article","resourceType":"学術雑誌論文(journal article)","notation":[{"@language":"ja","@value":"化学放射線療法を受ける高齢頭頸部がん患者の口腔内評価ツールの評価と看護実践"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1010584168958685953","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2023221183"}],"notation":[{"@language":"ja","@value":"化学放射線療法を受ける高齢頭頸部がん患者の口腔内有害事象に対する評価項目の検討"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1010861618242768896","@type":"Article","resourceType":"学術雑誌論文(journal article)","notation":[{"@language":"ja","@value":"化学放射線療法を受ける高齢頭頸部がん患者の口腔内有害事象に対する評価項目の検討"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050018296277596160","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5645"},{"@type":"NAID","@value":"120005954152"}],"notation":[{"@value":"Novel targets for natural killer/T-cell lymphoma immunotherapy"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050022853111466368","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/2000502"},{"@type":"DOI","@value":"10.1002/hed.27787"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.27787"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hed.27787"}],"notation":[{"@language":"en","@value":"Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD-L1 and PD-L2"},{"@value":"Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of\n                    <scp>PD‐L1</scp>\n                    and\n                    <scp>PD‐L2</scp>"},{"@value":"Combined Approach for Predicting the Efficacy of Nivolumab in Head and Neck Carcinoma by Tissue and Soluble Expressions of PD‐L1 and PD‐L2"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050299771254372480","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5357"},{"@type":"DOI","@value":"10.1038/srep16280"},{"@type":"URI","@value":"https://www.nature.com/articles/srep16280"},{"@type":"URI","@value":"https://www.nature.com/articles/srep16280.pdf"},{"@type":"PMID","@value":"26538233"},{"@type":"NAID","@value":"120005690964"}],"notation":[{"@value":"Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma."}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050581246231009792","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5694"},{"@type":"NAID","@value":"120006325057"}],"notation":[{"@value":"Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050581246231053824","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5500"},{"@type":"DOI","@value":"10.1007/s00262-015-1675-7"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00262-015-1675-7.pdf"},{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s00262-015-1675-7/fulltext.html"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00262-015-1675-7"},{"@type":"PMID","@value":"25754123"},{"@type":"NAID","@value":"120005774022"}],"notation":[{"@value":"CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma."}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050581246231165440","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5005"},{"@type":"NAID","@value":"120005464780"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2014228829"}],"notation":[{"@value":"Clear cell sarcoma-like gastrointestinal tumorの1例"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1050585803064888064","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/2000501"},{"@type":"DOI","@value":"10.1002/hed.27703"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.27703"}],"notation":[{"@language":"en","@value":"Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer"},{"@value":"Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230124941696","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1002/hed.23906"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhed.23906"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.23906"},{"@type":"PMID","@value":"25352398"}],"notation":[{"@value":"Assessment of the change in cetuximab‐induced antibody‐dependent cellular cytotoxicity activity of natural killer cells by steroid"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282454494976","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s00262-023-03394-7"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00262-023-03394-7.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00262-023-03394-7/fulltext.html"},{"@type":"PMID","@value":"36811663"}],"notation":[{"@value":"Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360022306717221504","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.21203/rs.3.rs-2553923/v1"},{"@type":"URI","@value":"https://www.researchsquare.com/article/rs-2553923/v1"},{"@type":"URI","@value":"https://www.researchsquare.com/article/rs-2553923/v1.html"},{"@type":"DOI","@value":"10.1007/s00262-023-03460-0"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00262-023-03460-0.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00262-023-03460-0/fulltext.html"},{"@type":"PMID","@value":"37173455"}],"notation":[{"@value":"Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer"},{"@language":"en","@value":"10.1007/s00262-023-03460-0."}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690846967296","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.coi.2016.11.001"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0952791516301492?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0952791516301492?httpAccept=text/plain"},{"@type":"PMID","@value":"27940327"}],"notation":[{"@value":"Peptide vaccines in cancer — old concept revisited"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709287255808","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/2162402x.2018.1466771"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1466771"},{"@type":"PMID","@value":"30510853"}],"notation":[{"@value":"Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285713602458112","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.2217/imt.15.103"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.2217/imt.15.103"},{"@type":"PMID","@value":"26642249"}],"notation":[{"@value":"Novel Targets for Natural Killer/T-cell Lymphoma Immunotherapy"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714434003712","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3389/fped.2019.00141"},{"@type":"URI","@value":"https://www.frontiersin.org/article/10.3389/fped.2019.00141/full"},{"@type":"PMID","@value":"31041299"}],"notation":[{"@value":"Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286996864893440","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1186/s12967-019-1957-5"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/s12967-019-1957-5.pdf"},{"@type":"URI","@value":"http://link.springer.com/article/10.1186/s12967-019-1957-5/fulltext.html"},{"@type":"PMID","@value":"31221178"}],"notation":[{"@value":"PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617809062784","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s00262-021-02864-0"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00262-021-02864-0.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00262-021-02864-0/fulltext.html"},{"@type":"PMID","@value":"33507344"}],"notation":[{"@value":"A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment"},{"@language":"en","@value":"10.1007/s00262-021-02864-0"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617810066176","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/2162402x.2020.1856545"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1856545"},{"@type":"PMID","@value":"33457076"}],"notation":[{"@value":"Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma"},{"@language":"en","@value":"10.1080/2162402X.2020.1856545"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757187452288","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/cas.15619"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15619"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.15619"},{"@type":"PMID","@value":"36285482"}],"notation":[{"@value":"Mitogen‐activated protein kinase inhibition augments the T cell response against <i>HOXB7</i>‐expressing tumor through human leukocyte antigen upregulation"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905163297408","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1002/hed.28151"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.28151"}],"notation":[{"@value":"Differences in <scp>PD</scp>‐<scp>L1</scp>, <scp>PD</scp>‐<scp>L2</scp>, and <scp>EGFR</scp> Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905173904640","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3390/cancers16173013"},{"@type":"URI","@value":"https://www.mdpi.com/2072-6694/16/17/3013/pdf"}],"notation":[{"@value":"Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166739676032","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1038/bjc.2013.577"},{"@type":"URI","@value":"http://www.nature.com/articles/bjc2013577.pdf"},{"@type":"URI","@value":"http://www.nature.com/articles/bjc2013577"},{"@type":"PMID","@value":"24045666"}],"notation":[{"@value":"EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092785778432","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s00262-021-02940-5"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00262-021-02940-5.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00262-021-02940-5/fulltext.html"},{"@type":"PMID","@value":"33866408"}],"notation":[{"@value":"Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579819986788352","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/2162402x.2021.2021619"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2021619"},{"@type":"PMID","@value":"35003900"}],"notation":[{"@value":"Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339779171200","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1159/000534516"},{"@type":"URI","@value":"https://karger.com/orl/article-pdf/86/1/41/4170955/000534516.pdf"},{"@type":"PMID","@value":"38091970"}],"notation":[{"@value":"Efficacy of Cetuximab Combined with Paclitaxel in Patients with Recurrent Salivary Gland Carcinoma: A Retrospective Observational Study"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339780488064","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3390/cancers16061205"},{"@type":"URI","@value":"https://www.mdpi.com/2072-6694/16/6/1205/pdf"}],"notation":[{"@value":"Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341840615808","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3390/vaccines12010045"},{"@type":"URI","@value":"https://www.mdpi.com/2076-393X/12/1/45/pdf"}],"notation":[{"@value":"Harnessing Immunity to Treat Advanced Thyroid Cancer"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658389014016","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1038/s41374-018-0182-9"},{"@type":"URI","@value":"http://www.nature.com/articles/s41374-018-0182-9.pdf"},{"@type":"URI","@value":"http://www.nature.com/articles/s41374-018-0182-9"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0023683722026174?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0023683722026174?httpAccept=text/plain"},{"@type":"PMID","@value":"30664711"}],"notation":[{"@value":"Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849941601899776","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.bbrc.2019.11.107"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0006291X19322338?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0006291X19322338?httpAccept=text/plain"},{"@type":"PMID","@value":"31771883"}],"notation":[{"@value":"Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861291388562944","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.tranon.2022.101358"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1936523322000201?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1936523322000201?httpAccept=text/plain"},{"@type":"PMID","@value":"35123188"}],"notation":[{"@value":"IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861705586887552","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3390/vaccines10010070"},{"@type":"URI","@value":"https://www.mdpi.com/2076-393X/10/1/70/pdf"},{"@type":"PMID","@value":"35062731"}],"notation":[{"@value":"Antitumor Peptide-Based Vaccine in the Limelight"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707368447744","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1002/lio2.863"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/lio2.863"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/lio2.863"},{"@type":"PMID","@value":"36544935"}],"notation":[{"@value":"The efficacy of <scp>PD</scp>‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865815501535104","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/cas.16079"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.16079"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2025175888"}],"notation":[{"@value":"Soluble <scp>CD27</scp> as a predictive biomarker for intra‐tumoral <scp>CD70</scp>/<scp>CD27</scp> interaction in nasopharyngeal carcinoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869856035148672","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s10157-024-02527-1"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s10157-024-02527-1.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s10157-024-02527-1/fulltext.html"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2025323923"}],"notation":[{"@value":"A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694365670320640","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s00262-020-02524-9"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s00262-020-02524-9.pdf"},{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s00262-020-02524-9/fulltext.html"},{"@type":"PMID","@value":"32086539"}],"notation":[{"@value":"Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer"},{"@language":"en","@value":"10.1007/s00262-020-02524-9"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204351289856","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.5648/jjiao.36.15"},{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jjiao/36/1/36_15/_pdf"},{"@type":"NAID","@value":"130006619256"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2018194255"}],"notation":[{"@language":"ja","@value":"鼻性NK/T細胞リンパ腫に対する革新的免疫療法の開発"},{"@language":"en","@value":"Innovative immunotherapy for nasal NK/T-cell lymphoma"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204353416704","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.5648/jjiao.32.185"},{"@type":"URI","@value":"https://asahikawa-med.repo.nii.ac.jp/records/5049"},{"@type":"NAID","@value":"130004697457"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2015149842"}],"notation":[{"@language":"en","@value":"Helper T-cell based immunotherapy combined with adjuvants in head and neck squamous cell carcinoma"},{"@language":"ja","@value":"ヘルパーT 細胞と免疫アジュバントを用いた頭頸部癌免疫治療の開発"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204991933184","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.15036/arerugi.61.1544_1"},{"@type":"NAID","@value":"110009621079"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2013096382"}],"notation":[{"@language":"ja","@value":"O59-6 アレルギーサイトカインであるIL-33の腫瘍における発現(サイトカイン・ケモカイン2,口演,第62回日本アレルギー学会秋季学術大会)"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205000855552","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.15036/arerugi.62.1406_2"},{"@type":"NAID","@value":"110009798225"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2014167587"}],"notation":[{"@language":"ja","@value":"O61-4 IL-33レセプターであるST-2の腫瘍における発現(O61 サイトカイン2,口演,第63回日本アレルギー学会秋季学術大会)"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288070428800","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.7248/jjrhi.57.243"},{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jjrhi/57/3/57_243/_pdf"},{"@type":"NAID","@value":"130007483506"}],"notation":[{"@language":"ja","@value":"上気道感染･アレルギー・腫瘍ワクチン療法：臨床への応用"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713062408576","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.7248/jjrhi.58.107"},{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jjrhi/58/1/58_107/_pdf"},{"@type":"NAID","@value":"130007636230"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2019308332"}],"notation":[{"@language":"ja","@value":"頭頸部癌に対する癌ペプチドワクチン療法の開発"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713083620608","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.7248/jjrhi.58.152"},{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jjrhi/58/2/58_152/_pdf"},{"@type":"NAID","@value":"130007681698"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2023114525"}],"notation":[{"@language":"en","@value":"Fifth Report of Hands-on Seminar on Basic Research for Clinicians at the 57<sup>th</sup> Annual Meeting of the Japanese Rhinologic Society"},{"@language":"ja","@value":"鼻科基礎研究ハンズオンセミナーの取り組み（第5報）"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1523669555705751808","@type":"Article","productIdentifier":[{"@type":"NDL_BIB_ID","@value":"029070594"},{"@type":"NDL_CALL_NUMBER","@value":"Z19-B207"},{"@type":"URI","@value":"http://id.ndl.go.jp/bib/029070594"},{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I029070594"},{"@type":"NAID","@value":"40021579492"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2018240973"}],"notation":[{"@value":"癌ワクチン療法における免疫アジュバント"},{"@language":"ja-Kana","@value":"ガン ワクチン リョウホウ ニ オケル メンエキ アジュバント"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"id:person:erad:00596306"},{"@type":"KAKEN","@value":"18H02948_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"24390385_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"20K11066_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"20K09724_MrEkXlr17xxCKsvbFqurH7YrGwT_principal_investigator"},{"@type":"KAKEN","@value":"23K08977_MrEkXlr17xxCKsvbFqurH7YrGwT_principal_investigator"},{"@type":"KAKEN","@value":"23K08903_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"23K08929_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"16K20223_MrEkXlr17xxCKsvbFqurH7YrGwT_principal_investigator"},{"@type":"KAKEN","@value":"24791735_MrEkXlr17xxCKsvbFqurH7YrGwT_principal_investigator"},{"@type":"KAKEN","@value":"21H03082_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"22K09699_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"25K00340_MrEkXlr17xxCKsvbFqurH7YrGwT_co_investigator_buntan"},{"@type":"KAKEN","@value":"26K12404_MrEkXlr17xxCKsvbFqurH7YrGwT_principal_investigator"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2001837091_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2001838885_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2005186387_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:1003976730_RBoyyyDUoIRp47pGJ4KGKmoUWHK"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2007182657_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2007306530_RBoyyyDUoIRp47pGJ4KGKmoUWHK"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:2004098141_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143939_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143619_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143277_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143993_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143779_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"IRDB","@value":"oai:irdb.nii.ac.jp:01468:0006143229_JsSCuIOTrEbZyY00HyQcfGEmmLi"},{"@type":"CIA","@value":"120006325057_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"110009621079_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"130007483506_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"120005954152_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"40021579492_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"120005690964_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"130004697457_SYXCcrRpyXjQmserRiajkuvvibQ"},{"@type":"CIA","@value":"130007681698_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"130006619256_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"120005774022_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"120005464780_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"130007636230_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CIA","@value":"110009798225_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R000000004-I029070594_MrEkXlr17xxCKsvbFqurH7YrGwT"},{"@type":"CROSSREF","@value":"10.1016/j.coi.2016.11.001_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1002/hed.23906_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1038/srep16280_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.7248/jjrhi.58.152_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1080/2162402x.2018.1466771_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.2217/imt.15.103_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.3389/fped.2019.00141_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1111/cas.15619_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.5648/jjiao.32.185_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1080/2162402x.2021.2021619_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.5648/jjiao.36.15_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1016/j.tranon.2022.101358_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.3390/vaccines10010070_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"CROSSREF","@value":"10.1002/lio2.863_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::b746b26d31314b7c3d5883450f04d55f_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::519ef789b18ed8aca9337bb1dbacdb8d_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::56b87e0c6c7fd57a86962555ca8569ba_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::d7bdba75d53a346c6bfa21be152ebd7d_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::0c00c015eeb41c5bdeee578b6a846749_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::0c78574536a378087033fa5c2c1988f1_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::aecf6831fd9a75251aa9c81e5d299e05_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::b9d23366c57605f8e9673d7b31e58eb6_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::6aa7a461f7815f48d26ece516da0e2ea_RmNW9kVihyuCyaOi7k94zzWIOv1"},{"@type":"OPENAIRE","@value":"doi_________::355f3efb7e8f9d202f7a896277797092_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::f86e3c430af88fecece6657f1b3558a9_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::db77ff9e261d66bce36be3ed490a0abb_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::158d0c9090cfe2225dfec3d19d46f49e_RmNW9kVihyuCyaOi7k94zzWIOv1"},{"@type":"OPENAIRE","@value":"doi_dedup___::bebf62bbbc2a5096baa089191e470a62_MWLFFdKEeWTnrb9WGQssTgg2izv"},{"@type":"OPENAIRE","@value":"doi_dedup___::c9fb6c786ff7a13ce9a7a240bcd846d2_MWLFFdKEeWTnrb9WGQssTgg2izv"}]}